Specialists at Abramson Cancer Center utilize modern tools to evaluate and develop individualized treatment plans for non-Hodgkin lymphoma.
Non-Hodgkin lymphomas are cancers of lymphocytes, which are white blood cells that circulate throughout the blood and bone marrow. These cancers are called "non-Hodgkin" because they have a different appearance from that of Hodgkin lymphomas.
Non-Hodgkin lymphoma may be difficult to diagnose and it’s very important to get an accurate subtype diagnosis.
Penn Medicine is a leader in treating non-Hodgkin lymphoma and develops personalized treatment plans for each individual.
Every step of cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex healthcare situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.